Publication | Closed Access

Maraviroc improves hepatic triglyceride content but not inflammation in a murine nonalcoholic fatty liver disease model induced by a chronic exposure to high-fat diet

High-fat DietFatty Liver DiseaseInflammationMetabolic SyndromeMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseHepatotoxicityHepatology FibrosisHealth SciencesMetabolic Associated SteatohepatitisLiver PhysiologyHepatology InflammationChronic ExposurePharmacologyDrug-induced Liver InjuryHepatic Triglyceride ContentHepatologyLiver DiseaseMedicine